GREAT POINT PARTNERS LLC - Q4 2010 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
No holdings reported for quarter Q4 2010
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
STREAMLINE HEALTH SOLUTNS, INC CMN25Q3 20192.5%
CYTOKINETICS INC18Q2 20247.1%
IOVANCE BIOTHERAPEUTICS, INC. CMN16Q1 202114.3%
ZOGENIX INC CMN16Q4 20198.8%
PTC THERAPEUTICS, INC. CMN16Q3 20239.9%
EXELIXIS, INC16Q1 20227.5%
SAGE THERAPEUTICS, INC CMN15Q3 202110.8%
ACADIA PHARMACEUTICALS, INC.14Q1 20218.8%
ACCELERON PHARMA INC CMN14Q2 20208.2%
CONNECTURE INC13Q4 201725.1%

View GREAT POINT PARTNERS LLC's complete holdings history.

Latest significant ownerships (13-D/G)
GREAT POINT PARTNERS LLC Q4 2010 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Context Therapeutics Inc.June 05, 20247,419,3559.9%
Outlook Therapeutics, Inc.April 08, 20242,231,32410.0%
ALPINE IMMUNE SCIENCES, INC.February 14, 20243,703,4336.4%
Avalo Therapeutics, Inc.February 14, 20242,0850.3%
HERON THERAPEUTICS, INC. /DE/Sold outFebruary 14, 202400.0%
Neurogene Inc.February 14, 2024994,2297.8%
OptiNose, Inc.February 14, 202411,484,12010.0%
PRECISION BIOSCIENCES INCSold outFebruary 14, 202400.0%
UroGen Pharma Ltd.February 14, 20242,620,5458.5%
Vistagen Therapeutics, Inc.February 14, 20242,792,92710.0%

View GREAT POINT PARTNERS LLC's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-30
SC 13G2024-08-15
13F-HR2024-08-14
SC 13G2024-08-05
SC 13G2024-07-18
SC 13G2024-06-05
13F-HR2024-05-15
SC 13G2024-04-08
13F-HR2024-02-14
SC 13G/A2024-02-14

View GREAT POINT PARTNERS LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export GREAT POINT PARTNERS LLC's holdings

CSVXLS